logo

For the Inventor, By the Inventor

Toyama, Japan

Kenji Takeda

This inventor holds 6 USPTO granted patents. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1986-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Takeda. Retrieved from https://idiyas.com/inventor/kenji-takeda-ql1ged3c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:

goldMedal6 out of 159 
 
Toyama Chemical Co., Ltd.
 patents

Years Active: 1986-1996

Loading Chart...
6 patents (USPTO):Explore Patents
1. 5578627 - 1,2-benzoisoxazole derivative or its salt and brain-protecting agent (1996-11-26),
2. 4948796 - Piperazine derivative or its salt, process for producing the same and (1990-08-14),
3. 4717767 - 7-amino-3-(pyrazinylmethyl) or (pyridazinylmethyl)-cephalosporins (1988-01-05),
4. 4667040 - Novel process for producing 2-(2-aminothiazol-4-yl)glyoxylic acid (1987-05-19),
5. 4618606 - Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) (1986-10-21),
6. 4563534 - Process for producing 2-(2-aminothiazol-4-yl)glyoxylic acid derivative (1986-01-07),

Title: Kenji Takeda: Innovator in Cerebrovascular Disease Treatment

Introduction

Kenji Takeda is a prominent inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cerebrovascular diseases. With a total of 6 patents to his name, Takeda's work has garnered attention in the scientific community.

Latest Patents

Among his latest patents are innovative compounds such as a 1,2-benzoisoxazole derivative or its salt, and a brain-protecting agent, specifically a piperazine derivative or its salt. These compounds are particularly noteworthy for their potential applications in curing cerebrovascular diseases and addressing post-cerebrovascular conditions. His research has led to the development of a piperazine derivative represented by a specific formula, which is useful in this medical field.

Career Highlights

Kenji Takeda has been associated with Toyama Chemical Co., Ltd., where he has played a crucial role in advancing pharmaceutical research. His dedication to innovation in drug development has positioned him as a key figure in the industry.

Collaborations

Takeda has collaborated with notable colleagues such as Hiroshi Sadaki and Hiroyuki Imaizumi, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kenji Takeda's contributions to the field of cerebrovascular disease treatment through his patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…